Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Kentucky | OTHER |
Not provided
Not provided
Not provided
This series of studies will explore the acceptability, feasibility, and preliminary efficacy of making access to smartphone applications contingent on objective evidence of smoking abstinence.
Aim 1 will use small focus groups and feedback sessions (n = 4-6) to gain insight into the acceptability and usability of Re-Connect. Up to 3 single-case design studies (n = 4/round) will then be conducted to get more extended use of the app in a real world context to get additional information about usability and acceptability of the app. Aim 2 will involve a 2-group (AC vs SC), pilot randomized control trial to test the feasibility, acceptability, and preliminary efficacy of Re-Connect.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Abstinent Contingent (AC) Re-Connect | Experimental | Participants in this group will be able to unblock highly desired, but non-essential (e.g., social networking, shopping, games) applications contingent on meeting goals for smoking abstinence, as verified by meeting carbon monoxide goals (CO<=6ppm). |
|
| Submission Contingent (SC) Re-Connect | Active Comparator | Participants in this group will also be able to unblock their applications, but contingent on submitting CO samples and independent of meeting CO goals for smoking abstinence. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Abstinent Contingent (AC) Re-Connect | Behavioral | Participants in this group will be able to unblock highly desired, but non-essential (e.g., social networking, shopping, games) applications contingent on meeting goals for smoking abstinence, as verified by meeting carbon monoxide goals (CO<=6ppm). |
| Measure | Description | Time Frame |
|---|---|---|
| System Usability Survey | A survey that participants in Aim 1 usability testing will complete after testing out the Re-Connect application. Focus and feedback group participants, as well as single-case design participants, will complete this survey and a score of 75 or higher will be required before moving to the RCT in Aim 2. | through study completion, up to 12-weeks |
| Reconnect use (RCT, Aim 2) | Over the 6-month observation period we will track the how much and to what extent participants use Re-Connect and continue to submit CO samples. | 6-months |
| Duration of Re-Connect Use (RCT, Aim 2) | Over the 6-month study we will track how long participants are engaged with using Re-Connect. | 6-months |
| Acceptability (RCT, Aim 2) | At three time points we will have the participants complete a Treatment Acceptability Questionnaire to provide quantitative and qualitative feedback on their experience with using Re-Connect. | 6-months |
| Percent negative carbon monoxide samples | We will compare the percentage of CO samples that meet the abstinence goals during the 6-month study. | 6-months |
| 7-day point prevalence of self-reported, and CO verified, smoking | Participants will provide self-reports and a CO sample to confirm smoking status throughout the 6-month study. | 6-months |
| Measure | Description | Time Frame |
|---|---|---|
| Initial Acceptability | Individuals who respond to our advertisement for a smoking cessation intervention will be given information about Re-Connect and then they will be given the option of continuing to participate or discontinuing. Participants who discontinue will be asked why they are not interested to inform future versions of the intervention to make it more widely acceptable and therefore more likely to be adopted by a broader population. |
| Measure | Description | Time Frame |
|---|---|---|
| Smartphone Use Moderators | Exploratory analyses will be conducted on potential moderator variables (e.g., baseline time spent on phone, number of apps downloaded/used, types of apps used). | 6-months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Bethany Raiff, PhD | Contact | 856-256-4500 | 53782 | raiff@rowan.edu |
| Name | Affiliation | Role |
|---|---|---|
| Bethany Raiff, PhD | Rowan University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rowan University | Recruiting | Glassboro | New Jersey | 08028 | United States |
De-identified data will be shared if there is an appropriate need expressed by the investigator.
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D016540 | Smoking Cessation |
| D010342 | Patient Acceptance of Health Care |
| D014029 | Tobacco Use Disorder |
| ID | Term |
|---|---|
| D015438 | Health Behavior |
| D001519 | Behavior |
| D000074822 | Treatment Adherence and Compliance |
| D019966 | Substance-Related Disorders |
Not provided
Not provided
Aim 1 will use small focus groups and feedback sessions (n = 4-6) to gain insight into the acceptability and usability of Re-Connect. Up to 3 single-case design studies (n = 4/round) will then be conducted to get more extended use of the app in a real world context to get additional information about usability and acceptability of the app. Aim 2 will involve a 2-group (AC vs SC), pilot randomized control trial to test the feasibility, acceptability, and preliminary efficacy of Re-Connect.
Not provided
Not provided
Participants will be told how they can earn back access to their applications but they will not be told whether this is considered the active or control condition.
|
| Submission Contingent (SC) Re-Connect | Behavioral | Participants in this group will also be able to unblock their applications, but contingent on submitting CO samples and independent of meeting CO goals for smoking abstinence. |
|
| 1 day |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |